Article
The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.
Molecular and cellular biochemistry - 1 Nov 2016
Lu Ming, Zhang Jianzhong, Li Ming, Ge Xiaoxu, Dai Xu, Zhao Jiao, Fu Mingzhou, Wang Tao, Fang Xiyao, Li Can, Zhang Rong, Zhao Weijing, Zheng Taishan, Wang Feng, Yu Ming, Lei Tao, Wang Niansong, Bao Yuqian, Liu Limei, Liu Yanjun, Jia Weiping
Abstract excerpt
Whether the DD genotype of the angiotensin-I converting enzyme (ACE) I/D variation contributes to end-stage renal disease (ESRD) risk in type 2 diabetes mellitus (T2DM) remains controversial. Differences in study design, case and control definition, sample size and ethnicity may contribute to the discrepancies reported in association studies. We performed a case-control study to evaluate the association of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.